FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ADRIXETINIB
异名/同义词1H-PYRAZOLE-3-CARBOXAMIDE, N-(5-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)-2-PYRIDINYL)-1-PROPYL-4-(2,2,2-TRIFLUOROETHOXY)-
ADRIXETINIB
ADRIXETINIB [INN]
ADRIXETINIB [WHO-DD]
N-(5-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)-2-PYRIDINYL)-1-PROPYL-4-(2,2,2-TRIFLUOROETHOXY)-1H-PYRAZOLE-3-CARBOXAMIDE
N-(5-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PYRIDIN-2-YL)-1-PROPYL-4-(2,2,2-TRIFLUOROETHOXY)-1H-PYRAZOLE-3-CARBOXAMIDE
N-(5-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PYRIDIN-2-YL)-1-PROPYL-4-(2,2,2-TRIFLUOROETHOXY)-1H-PYRAZOLE-3-CARBOXAMIDE
CAS登记号2394874-66-7
物质唯一标识(Unique Ingredient Identifier)JIJ7I9XO8B
分子式C25H24F3N5O5
国际化合物标识(International Chemical Identifier,InChI)BWUUJXXFCSYLFW-UHFFFAOYSA-N
SMILESO(c1c2c(cc(c(c2)OC)OC)ncc1)c3ccc(nc3)NC(=O)c4c(OCC(F)(F)F)cn(n4)CCC
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System